Glaxo Faces Talent ‘War’ in Emerging-Market Race With Pfizer
This article is for subscribers only.
GlaxoSmithKline Plc is grappling with a “war for talent” in China and India as the U.K. drugmaker struggles to retain sales representatives needed to expand in the world’s fastest-growing markets.
About 20 percent of Glaxo’s sales force in both countries quits each year in favor of better offers from rivals, said Abbas Hussain, 46, the London-based company’s president of emerging markets. That rate is about the same as the industry average in China and India, Hussain said in a March 28 interview at his office in Singapore.